List of Dotmatics Luma Customers
Woburn, 1801, MA,
United States
Since 2010, our global team of researchers has been studying Dotmatics Luma customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Dotmatics Luma for Laboratory Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Dotmatics Luma for Laboratory Management include: BASF, a Germany based Life Sciences organisation with 111408 employees and revenues of $75.74 billion, Krystal Biotech, Inc., a United States based Life Sciences organisation with 119 employees and revenues of $3.0 million, Addex Therapeutics Ltd, a Switzerland based Life Sciences organisation with 26 employees and revenues of $2.7 million and many others.
Contact us if you need a completed and verified list of companies using Dotmatics Luma, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Dotmatics Luma customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Addex Therapeutics Ltd | Life Sciences | 26 | $3M | Switzerland | GraphPad Software | Dotmatics Luma | Laboratory Management | 2023 | n/a |
In 2023 Addex Therapeutics Ltd centralized and modernized its small-molecule drug discovery data on Dotmatics Luma as the company platform for Laboratory Management. The initiative targeted consolidation of experimental and assay datasets to improve data access and accelerate analysis for R&D teams based in Switzerland.
The implementation emphasized a centralized data repository, standardized analytical workflows, and configurable visualization and reporting capabilities consistent with Laboratory Management systems. Dotmatics Luma was used to unify experiment records, enable interactive analytics across chemistry and assay results, and provide searchable, curated datasets for bench scientists and data analysts.
Operational scope covered Addex R&D groups in Switzerland, prioritizing day to day lab operations, data analysis, and cross functional collaboration between chemists and biologists. The deployment approach included staged adoption and plans for future roll out of additional Dotmatics functionality to broaden coverage across R&D workflows.
Governance focused on standardizing data models and establishing repeatable analysis workflows to reduce manual data handling and improve reproducibility within Laboratory Management processes. The case study reports an approximately 50% reduction in time spent analysing data for R&D teams following adoption of Dotmatics Luma.
|
 |
BASF | Life Sciences | 111408 | $75.7B | Germany | GraphPad Software | Dotmatics Luma | Laboratory Management | 2019 | n/a |
In 2019, BASF Agricultural Solutions implemented Dotmatics Luma as part of a Data to Value R&D digitalization initiative to centralize experiment capture and standardize electronic lab notebook workflows across chemistry and materials research. The deployment was oriented to Laboratory Management requirements, with a primary focus on ELN provisioning for bench chemists and materials scientists in Europe, aligning the application to R&D data capture and discovery use cases.
The Dotmatics Luma implementation emphasized structured experiment capture, searchable metadata and visualization and aggregation capabilities to support cross experiment comparison. Configuration work included ELN templates and instrument result attachments, category aligned automation for experiment versioning and traceability, and data visualization layers to aggregate experimental results for decision support in research workflows.
Operational rollout covered BASF Agricultural Solutions research groups and laboratory sites in Europe, embedding the Laboratory Management application into chemistry and materials R&D processes. The program centralized experiment data and improved accessibility for scientists and project leads, and the implementation architecture supported consolidated data stores and indexed search to surface experimental context and provenance.
Governance changes accompanied the technical rollout, instituting standardized capture procedures, role based access for lab staff and project owners, and workflow orchestration for experiment review and sign off. Outcomes explicitly included improved search, traceability and decision making driven by centralized experiment capture and enhanced data visualization and aggregation capability.
|
 |
Krystal Biotech, Inc. | Life Sciences | 119 | $3M | United States | GraphPad Software | Dotmatics Luma | Laboratory Management | 2023 | n/a |
In 2023, Krystal Biotech, Inc. implemented Dotmatics Luma as part of a Dotmatics ELN and Platform deployment to support Laboratory Management for its gene-therapy research in the United States. The initiative targeted standardization of experiment capture, improvement of cross-functional collaboration, and creation of secure, searchable R&D data stores to support ongoing development programs.
The deployment centered on the Dotmatics ELN capability within Dotmatics Luma to provide structured experiment documentation, centralized data capture, and searchable experimental records. Configuration work focused on standardized experiment templates, metadata capture to enable retrieval across projects, and role based access controls to protect sensitive gene-therapy research data while enabling team collaboration and review workflows.
Operational coverage remained concentrated on R&D functions involved in gene-therapy development, with plans to adopt additional Dotmatics apps and tools as the organization scales. Governance changes emphasized consistent documentation practices and a single, indexed laboratory record for research reproducibility and cross-team sharing, aligning Laboratory Management tooling with Krystal Biotech business functions in research and development.
|
Buyer Intent: Companies Evaluating Dotmatics Luma
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||